Notes
NPRA = National Pharmaceutical Regulatory Agency
Reference
National Pharmaceutical Regulatory Agency, Ministry of Health Malaysia. Imovane (zopiclone): New restriction of the indication and additional warnings on abuse and dependence. Internet Document : 20 Jun 2019. Available from: URL: https://www.npra.gov.my/index.php/en/component/content/article/414-english/safety-alerts-main/safety-alerts-2019/
Rights and permissions
About this article
Cite this article
Imovane: risk of drug abuse, dependence. Reactions Weekly 1760, 3 (2019). https://doi.org/10.1007/s40278-019-64162-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-64162-9